172 related articles for article (PubMed ID: 35474665)
1. Use of metallic and polymeric ureteral stents in malignant ureteral obstruction.
Ohtaka M; Kawahara T; Hayashi Y; Kobayashi R; Tsutsumi S; Ousaka K; Takizawa A; Kishida T; Yao M; Uemura H
BJUI Compass; 2021 Jan; 2(1):58-63. PubMed ID: 35474665
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
4. Application of resonance metallic stents for malignant ureteral obstruction.
Kang Q; Jiang F; Yu Y; Shen C; Lv H; Yang B
Minim Invasive Ther Allied Technol; 2018 Dec; 27(6):333-338. PubMed ID: 29475395
[No Abstract] [Full Text] [Related]
5. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
6. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents.
Asakawa J; Iguchi T; Tamada S; Ninomiya N; Kato M; Yamasaki T; Nakatani T
Cancer Manag Res; 2018; 10():2977-2982. PubMed ID: 30214292
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Double-J Metallic Mesh Ureteral Stents for Malignant Ureteral Obstruction: A Retrospective Study.
Hori T; Makino T; Kawahara T; Urata S; Miyagi T
In Vivo; 2023; 37(2):806-810. PubMed ID: 36881102
[TBL] [Abstract][Full Text] [Related]
9. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
[TBL] [Abstract][Full Text] [Related]
10. The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.
Miyazaki J; Onozawa M; Takahashi S; Maekawa Y; Yasuda M; Wada K; Maeda Y; Masaki T; Yamaguchi A; Suzuki M; Sakai Y; Kimura T; Takai M; Seike K; Hashimoto T; Yamamoto S
BMC Urol; 2019 Dec; 19(1):137. PubMed ID: 31881875
[TBL] [Abstract][Full Text] [Related]
11. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of metallic stents for malignant ureteral obstruction.
Goldsmith ZG; Wang AJ; Bañez LL; Lipkin ME; Ferrandino MN; Preminger GM; Inman BA
J Urol; 2012 Sep; 188(3):851-5. PubMed ID: 22819410
[TBL] [Abstract][Full Text] [Related]
13. A single-institution experience with metallic ureteral stents: a cost-effective method of managing deficiencies in ureteral drainage.
Baumgarten AS; Hakky TS; Carrion RE; Lockhart JL; Spiess PE
Int Braz J Urol; 2014; 40(2):225-31. PubMed ID: 24856490
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a covered metallic ureteral stent and a double-J stent for malignant ureteral obstruction in advanced gastric cancer.
Kim ET; Yang WJ; Shin JH; Cho SJ; Song SY; Song MG; Kang D
Clin Radiol; 2021 Jul; 76(7):519-525. PubMed ID: 33736879
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost-utility analysis.
Cooper DM; Lines R; Shergill I
BJUI Compass; 2024 May; 5(5):465-475. PubMed ID: 38751954
[TBL] [Abstract][Full Text] [Related]
16. Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents.
Chen Y; Liu CY; Zhang ZH; Xu PC; Chen DG; Fan XH; Ma JC; Xu YP
World J Surg Oncol; 2019 Apr; 17(1):74. PubMed ID: 31039812
[TBL] [Abstract][Full Text] [Related]
17. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
[TBL] [Abstract][Full Text] [Related]
18. [Indwelling of Full-Length Metallic Ureteral Stents as an Initial Treatment for Patients with Untreated Malignant Ureteral Obstruction].
Tsurusaki T; Asai A; Imasato Y
Hinyokika Kiyo; 2018 Feb; 64(2):35-39. PubMed ID: 29684946
[TBL] [Abstract][Full Text] [Related]
19. Metallic full-length ureteral stents: does urinary tract infection cause obstruction?
Brown JA; Powell CL; Carlson KR
ScientificWorldJournal; 2010 Aug; 10():1566-73. PubMed ID: 20730376
[TBL] [Abstract][Full Text] [Related]
20. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
